How to Prioritize Lithium for Suicide Risk in Bipolar Disorder
How should clinicians prioritize lithium when treating adolescents and adults with bipolar disorder who have elevated suicide risk?
Patients with bipolar disorder commonly present with suicidal ideation, suicide attempts, and other self-harm concerns, and clinicians often need to decide whether lithium should be part of maintenance treatment when suicide prevention is a priority. In Association of Lithium Use With Suicide and Self-Harm Among Chinese Adolescents and Adults With Bipolar Disorder: A Nationwide Multicenter Retrospective Cohort Study, sustained lithium exposure was associated with lower past-year suicidal ideation and suicidal behaviors, making it a clinically relevant option to weigh deliberately rather than overlook.
-
Identify bipolar disorder patients with active suicide-prevention needs
Apply this workflow to adolescents and adults aged 12 to 45 years with bipolar disorder, especially those with current or recent suicidal ideation, prior suicidal ideation, prior suicide attempt, or other high-risk illness features. In this cohort, suicide-related burden was high, with 59.3% reporting past-year suicidal ideation and 24.4% reporting at least 1 suicide attempt, so the article supports considering suicidality directly in treatment planning.
-
Assess suicidality across the full spectrum, not attempts alone
Evaluate suicidal ideation as a primary target, including earlier forms such as wish to be dead and nonspecific active suicidal thoughts, in addition to suicidal behaviors. The study used a structured interview adapted from the Columbia-Suicide Severity Rating Scale 5-level hierarchy and found lower rates with lithium for overall suicidal ideation, wish to be dead, and nonspecific active suicidal thoughts, indicating that these earlier cognitive stages are clinically meaningful treatment targets.
-
Differentiate suicidal behaviors from nonsuicidal self-injury
Assess suicide attempts and related suicidal behaviors separately from nonsuicidal self-injury rather than treating all self-harm as one outcome. This distinction matters because lithium use was associated with lower suicidal behaviors overall, but nonsuicidal self-injury did not differ significantly between groups.
-
Prioritize sustained lithium exposure when selecting maintenance treatment
When choosing a maintenance strategy for bipolar disorder in a patient with elevated suicide risk, give lithium specific consideration because the study found lower adjusted odds of past-year suicidal ideation with lithium use compared with no lithium exposure. In this cohort, lithium use was associated with reduced suicidal ideation with an adjusted odds ratio of 0.57 and reduced suicidal behaviors with an adjusted odds ratio of 0.60, and most lithium-treated patients continued treatment throughout the year with a mean exposure of 338 days.
-
Document relevant modifiers before interpreting expected benefit
Review whether the patient has comorbid anxiety, a history of rapid cycling, predominant depressive episode type, psychotic symptoms, and age group, because the observed protective association was not equally robust across all subgroups. Exploratory analyses suggested stronger associations in females, adults aged 18 years or older, higher-income individuals, and those without comorbid anxiety or rapid cycling, while the association was not significant in adolescents younger than 18 years or in those with predominant depressive episode type.
-
Monitor hostility alongside mood symptoms and suicidality
Track aggression-related features, particularly hostility, as part of follow-up when lithium is used for a patient with bipolar disorder and suicide risk. The lithium group had lower hostility scores than the non-lithium group, which the article highlights as a potentially relevant clinical correlate when evaluating lithium's antisuicidal association.
-
Interpret suicide-attempt prevention cautiously
Use the ideation and overall suicidal behavior findings more confidently than any claim about time to first suicide attempt. The survival analysis showed only a nonsignificant trend toward lower risk of suicide attempt with lithium, with an adjusted hazard ratio of 0.74 and P = .08, so the article does not support claiming definitive protection against attempts or suicide death.
Clinical Considerations
- The study was observational and retrospective, so it supports an association between lithium use and lower suicidality rather than proving causation.
- Past-year suicidality was assessed retrospectively, which introduces recall bias and may blur timing between the observation year and earlier periods.
- The study could not determine the exact sequence of lithium exposure and suicidal ideation within the 1-year window, so reverse causality cannot be excluded.
- Most participants were from urban tertiary hospitals in China, which limits generalizability to rural or community settings and to other populations.
Bottom Line
For patients with bipolar disorder in whom suicide prevention is a treatment priority, sustained lithium treatment should be deliberately prioritized as a maintenance option because it was associated with markedly lower suicidal ideation and lower suicidal behaviors over 1 year.
